| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
2 companies
Emily Luisa Hill is Chief Financial Officer at REPL, with reported holdings spanning 2 companies. From January 2020 to August 2026, the filings on record show 0 open-market purchases and 23 sales. Emily Luisa Hill's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $7.1M at current prices.
Our model assigns Emily Luisa Hill a middling insider score of 59/100, based on 15 past trades. Over a 12-month horizon, 64.3% of those trades were profitable, with an average 12-month return of +10.8%.
Emily Luisa Hill's largest disclosed position is in REPL as Chief Financial Officer, worth about $4.5M. The REPL filings lean toward selling, a net 49,143 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2020 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 2,581 | $52.50 | $135,502.50 | -15.9% | |
| Jan 23, 2020 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 330 | $53.25 | $17,571.51 | -4.6% | |
| Jan 7, 2020 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 384 | $48.41 | $18,588.05 | -5.0% |